Whitepapers


All series


All Whitepapers

Kidney transporter models are essential for identifying renal toxicity. Learn how immortalized primary renal tubule epithelial models stably expressing OAT1, OCT2 or OAT3 protein were tested for functionality.

The Cubis® II balance series was designed for customizable modularity, which means the user can choose from many hardware and software options for thousands of different configurations. Meet the requirements of the pharmaceutical industry with a combination of the MCA high-end 7” display and specific QApp pharma package, providing all features needed for a full pharma-compliant lab balance system.

Soft gel capsules are dosage forms that have an oblong and smooth casing that encapsulates a liquid. The soft gel casing (or gel-mass) is formulated by mixing together gelatin (or alternative material) with water, plasticizer and other ingredients. Historically, soft gel casings have been prepared in a batch mixing operation that takes many hours to complete.

ORC International’s report Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing explores causes, consequences, and potential solutions to forecasting challenges related to biopharmaceutical drug substance manufacturing. It provides insight and perspective on key themes that emerge from the report, offering additional solutions to prepare for inevitable forecast inaccuracies.

Learn how you can bypass lengthy customizations by deploying a purpose-built LIMS. Pre-configured, pre-validated lab information management systems save time and money, reduce risk, keep you focused, and future-proof your lab.

Cancer researchers are challenged by the lack of precise disease models. Genome editing was used to create an isogenic lung cancer cell line that was tested for drug sensitivity.

• WorkBeads™ 40 TREN is an excellent tool as a guard column upstream protein A resins • WorkBeads 40 TREN removes ~99% of HCD, reduces HCP ~3-fold & removes >93% of endotoxins WorkBeads affimAb in a single step gives a 10-fold more pure mAb eluate than MaSelect SuRe™

This report examines the results of a Pharmaceutical Technology survey on 2018 quality goals and obstacles. The report findings offer insight into how quality teams can impact company-wide performance in 2018.